A fragile cleanup system sitting on the surface of brain cells may help explain one of Alzheimer’s disease’s oldest mysteries ...

The Alzheimer's risk gene APOE ε4 drives the aggressive, brain-wide Type 2 subtype of ALS, causing cognitive decline.

Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer Disease ...

Before turning to the quarter, I'd like to begin by recapping the Q1 announcements we highlighted on our last earnings call.

A new U.K. study suggests that biological age, measured through blood markers tied to inflammation and metabolism, may help ...

Can your lifestyle help you live longer? According to one Oxford University study, the answer is a resounding, "yes." ...

A person’s body can age faster than the calendar suggests, and that gap may carry important clues about dementia risk. In a study of more than 220,000 UK Biobank participants, researchers at King’s ...

Here’s what doctors want you to know about signs of Alzheimer’s disease.

Greater brain reserve and higher socioeconomic status were associated with reduced cognitive vulnerability to Alzheimer disease pathology among cognitively unimpaired older adults. Greater cognitive ...

Plasma p-tau217 was the strongest individual biomarker for predicting progression to Alzheimer's disease dementia in patients ...

Sit down, brain—a different organ takes the mic in a new study on the Christchurch variant of ApoE3. In the May 6 Neuron, scientists report that the liver cleared more brain amyloid when it produced ...

A research team at the Brain Research Institute, Niigata University has found that APOE ε4, a genetic factor best known for increasing the risk of Alzheimer's disease, may also influence how ...